New Clinical Data Demonstrating the Safety and Accuracy of Eversense through 365 Days Presented at the American Diabetes Association 83rd Scientific SessionsBusiness Wire • 06/26/23
Senseonics shares jump 6.7% on new insurance coverage for continuous glucose monitorMarket Watch • 06/02/23
Senseonics Announces UnitedHealthcare Coverage of Eversense® E3 CGM for Adults with DiabetesBusiness Wire • 06/02/23
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/09/23
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEMPRNewsWire • 05/09/23
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern TimeBusiness Wire • 04/27/23
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOKPRNewsWire • 04/24/23
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical TrialBusiness Wire • 04/18/23
Top 5 Health Care Stocks That Preparing To Pump This Quarter - Enovis (NYSE:ENOV), Esperion Therapeutics (NASDAQ:ESPR)Benzinga • 03/29/23
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsBusiness Wire • 03/15/23
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023Business Wire • 02/17/23
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)PRNewsWire • 11/03/22
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern TimeBusiness Wire • 10/25/22
Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare ConferenceBusiness Wire • 09/07/22